Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Osteoporosis and Multiple Sclerosis: Risk Factors, Pathophysiology, and Therapeutic Interventions.
The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models.
Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a new class of nanomolar FKBP12 ligands.
Complete bilateral horizontal internuclear ophthalmoplegia as a sign of multiple sclerosis relapse.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.
Neuroscience. To learn is to myelinate.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
In vivo detection of experimental optic neuritis by pupillometry.
Female reproductive issues in multiple sclerosis.
[Differential diagnosis between multiple sclerosis and neurological presentations of HIV-infection: a literature review and a case report].
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Vitamin D in health and disease: a literature review.
Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Pages
« first
‹ previous
…
258
259
260
261
262
263
264
265
266
…
next ›
last »